Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
1.000 |
None |
0.961 |
283 |
53
|
1997 |
2020 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
620
|
64
|
0.480 |
None |
1.000 |
9 |
4
|
2004 |
2017 |
Obesity, Morbid
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
203
|
49
|
0.400 |
None |
0.977 |
43 |
6
|
1999 |
2019 |
Hyperphagia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
60
|
3
|
0.400 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.310 |
None |
1.000 |
3 |
|
2008 |
2019 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.310 |
None |
1.000 |
2 |
|
2008 |
2019 |
Body Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
57
|
92
|
0.300 |
None |
1.000 |
2 |
|
2012 |
2012 |
Cocaine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
199
|
39
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Exogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Anhedonia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
93
|
7
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Compensatory Hyperinsulinemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
30
|
2
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Endogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Obesity due to melanocortin 4 receptor deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.220 |
None |
1.000 |
4 |
|
2005 |
2018 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.210 |
None |
1.000 |
2 |
|
2010 |
2017 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.200 |
None |
0.963 |
27 |
1
|
2001 |
2019 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.200 |
None |
0.933 |
15 |
|
2009 |
2019 |
Fatty Liver, Alcoholic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
94
|
6
|
0.200 |
None |
1.000 |
2 |
|
2005 |
2011 |
Sciatic Neuropathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
115
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Acute-Phase Reaction
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
24
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Bradycardia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
63
|
2
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.120 |
None |
1.000 |
6 |
1
|
1999 |
2019 |